When cancer occurs, IL-10 and TGF-β secreted by TAMs can prevent an antitumor immune response by inhibiting the function of antigen-presenting cells and effector T cells, leading to the escape of cancer cells and the formation of an immunosuppressive TME [62]. This evidence concerns the gene TGFB1 and cancer.